Last reviewed · How we verify

NCT05520021: MgSO4

The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat

Status unknown NA Last updated 15 September 2022
What this trial tests

NA trial testing Nifedipine in Preterm Labor Without Delivery in 30 participants. Status unknown.

Timeline
1 September 2022
Primary endpoint
31 December 2022
31 March 2023

Quick facts

Lead sponsorKonya Meram State Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposetreatment
Enrollment30
Start date1 September 2022
Primary completion31 December 2022
Estimated completion31 March 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Konya Meram State Hospital

Who can join

Adults 18 to 38, female only, with Preterm Labor Without Delivery or Pregnancy Preterm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of the effects of Nifedipine and MgSO4 therapies on maternal and fetal blood flow.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Nifedipine

Trials testing the same drug.

Other Konya Meram State Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05520021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing